Indoprofen compared with naproxen and placebo in rheumatoid arthritis. 1981

H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon

Thirty-six patients suffering from rheumatoid arthritis took part in a double-blind controlled cross-over trial, in which they received either indoprofen 800 mg daily, naproxen 500 mg daily, or a matching placebo. Each treatment was administered for two weeks. Indoprofen was shown to be significantly superior as an analgesic and in improving grip strength, and was the drug the patients preferred. Adverse effects were comparable, although indigestion was seen slightly more often during indoprofen treatment. Indoprofen is therefore at least as effective as existing anti-inflammatory drugs in rheumatoid arthritis and should be used as an alternative.

UI MeSH Term Description Entries
D007216 Indoprofen A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p21) Dexindoprofen
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1981, European journal of rheumatology and inflammation,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1981, European journal of rheumatology and inflammation,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
April 1975, Journal of clinical pharmacology,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
February 1984, Ryumachi. [Rheumatism],
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1973, Scandinavian journal of rheumatology. Supplement,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1981, European journal of rheumatology and inflammation,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1977, Proceedings of the Royal Society of Medicine,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1973, Scandinavian journal of rheumatology. Supplement,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
April 1999, Annals of the rheumatic diseases,
H Berry, and L Fernandes, and A K Clarke, and E B Hamilton, and J Davies, and A S Dixon
January 1981, European journal of rheumatology and inflammation,
Copied contents to your clipboard!